Multiple endocrine neoplasia type 1 differential diagnosis: Difference between revisions
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) |
||
Line 12: | Line 12: | ||
|+ | |+ | ||
! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Disease}} | ! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Disease}} | ||
! rowspan="2" |Gene | ! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Gene}} | ||
! rowspan="2" |Chromosome | ! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Chromosome}} | ||
! rowspan="2" |Differentiating Features | ! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Differentiating Features}} | ||
! colspan="3" |Components of MEN | ! colspan="3" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Components of MEN}} | ||
! rowspan="2" |Diagnosis | ! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Diagnosis}} | ||
|- | |- | ||
!Parathyroid | !style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Parathyroid}} | ||
!Pitutary | !style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Pitutary}} | ||
!Pancreas | !style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Pancreas}} | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |[[von Hippel-Lindau syndrome]] | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |[[von Hippel-Lindau syndrome]] | ||
|Von Hippel–Lindau tumor suppressor | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Von Hippel–Lindau tumor suppressor | ||
|3p25.3 | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |3p25.3 | ||
| | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | ||
* Angiomatosis, | * Angiomatosis, | ||
* Hemangioblastomas, | * Hemangioblastomas, | ||
Line 35: | Line 35: | ||
| | | | ||
| | | | ||
| + | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | + | ||
| | | | ||
* Clinical diagnosis | * Clinical diagnosis |
Revision as of 16:53, 17 October 2017
Multiple endocrine neoplasia type 1 Microchapters |
Differentiating Multiple endocrine neoplasia type 1 from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Multiple endocrine neoplasia type 1 differential diagnosis On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 1 differential diagnosis |
FDA on Multiple endocrine neoplasia type 1 differential diagnosis |
CDC on Multiple endocrine neoplasia type 1 differential diagnosis |
Multiple endocrine neoplasia type 1 differential diagnosis in the news |
Blogs on Multiple endocrine neoplasia type 1 differential diagnosis |
Directions to Hospitals Treating Multiple endocrine neoplasia type 1 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 1 differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Multiple endocrine neoplasia type 1 must be differentiated from other hereditary diseases such as von Hippel-Lindau syndrome, tuberous sclerosis, carney complex, neurofibromatosis type 1, Li-Fraumeni syndrome, multiple endocrine neoplasia type 2, familial hyperparathyroidism, pheochromocytoma and acromegaly.
Differential Diagnosis
Multiple endocrine neoplasia type 1 must be differentiated from the hereditary diseases shown in the table below.
Disease | Gene | Chromosome | Differentiating Features | Components of MEN | Diagnosis | ||
---|---|---|---|---|---|---|---|
Parathyroid | Pitutary | Pancreas | |||||
von Hippel-Lindau syndrome | Von Hippel–Lindau tumor suppressor | 3p25.3 |
|
+ |
| ||
Carney complex | PRKAR1A | 17q23-q24 |
|
- | - | - |
|
Neurofibromatosis type 1 | RAS | 17 | - | - | - | Prenatal
Postnatal Cardinal Clinical Features" are required for positive diagnosis.
| |
Li-Fraumeni syndrome | TP53 | 17 | Early onset of diverse amount of cancers such as | - | - | - |
Criteria
|
Gardner's syndrome | APC | 5q21 |
|
- | - | - |
|
Multiple endocrine neoplasia type 2 | RET |
|
+ | - | - |
Criteria Two or more specific endocrine tumors
| |
Cowden syndrome | PTEN | Hamartomas, | - | - | - |
| |
Acromegaly/gigantism |
|
- | + | - |
| ||
Pituitary adenoma |
|
+ |
| ||||
Hyperparathyroidism | + | - | - |
| |||
Pheochromocytoma/paraganglioma | VHL
RET NF1 SDHB SDHD |
Characterized by | - | - | - |
| |
Adrenocortical carcinoma | p53
Retinoblastoma h19 insulin-like growth factor II (IGF-II) p57kip2 |
17p, 13q |
|
- | - | - |
|
Adapted from Toledo SP, Lourenço DM, Toledo RA. A differential diagnosis of inherited endocrine tumors and their tumor counterparts, journal=Clinics (Sao Paulo), volume= 68, issue= 7, 07/24/2013[1] |
References
- ↑ Toledo SP, Lourenço DM, Toledo RA (2013). "A differential diagnosis of inherited endocrine tumors and their tumor counterparts". Clinics (Sao Paulo). 68 (7): 1039–56. doi:10.6061/clinics/2013(07)24. PMC 3715026. PMID 23917672.